Does universal active MRSA surveillance influence anti-MRSA antibiotic use? A retrospective analysis of the treatment of patients admitted with suspicion of infection at Veterans Affairs Medical Centers between 2005 and 2010
Author(s) -
Makoto Jones,
Benedikt Huttner,
Molly Leecaster,
Angela Huttner,
K. Damal,
William R. Tanner,
Christopher Nielson,
Michael Rubin,
Matthew Bidwell Goetz,
Karl MadarasKelly,
Matthew H. Samore
Publication year - 2014
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dku299
Subject(s) - medicine , veterans affairs , methicillin resistant staphylococcus aureus , antibiotics , emergency medicine , logistic regression , vancomycin , retrospective cohort study , pediatrics , intensive care medicine , staphylococcus aureus , microbiology and biotechnology , biology , bacteria , genetics
After the implementation of an active surveillance programme for MRSA in US Veterans Affairs (VA) Medical Centers, there was an increase in vancomycin use. We investigated whether positive MRSA admission surveillance tests were associated with MRSA-positive clinical admission cultures and whether the availability of surveillance tests influenced prescribers' ability to match initial anti-MRSA antibiotic use with anticipated MRSA results from clinical admission cultures.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom